BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-12 out of 12 found
  Current Search:  proteus: 12     

HTML
100%
US drug firm to open research unit in Qatar
BY SATISH KANADY DOHA: The US pharmaceutical major Panacea will open a state-of-the-art Cancer Research Centre at Qatar Science and Technology Park (QSTP).

The QSTP Center will be Panacea's first and exclusive research institute for the...

Qatar Peninsula:  Nov 19 2008 12:55PM
Matching: proteus
Find similar documents
HTML
100%
US drug firm to open research unit in Qatar
DOHA: The US pharmaceutical major Panacea will open a state-of-the-art Cancer Research Centre at Qatar Science and Technology Park (QSTP).

The QSTP Center will be Panacea's first and exclusive research institute for the MENA region,...

Zawya.com:  Nov 19 2008 12:34PM
Matching: proteus
Find similar documents
HTML
100%
New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria
WASHINGTON, Oct.

27 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

(J&JPRD), today announced new study results that demonstrate doripenem (DORIBAX(TM), doripenem for injection), a...

KLFY:  Oct 27 2008 9:29PM
Matching: proteus
Find similar documents
HTML
100%
New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria
WASHINGTON, Oct.

27 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

(J&JPRD), today announced new study results that demonstrate doripenem (DORIBAX(TM), doripenem for injection), a...

Montana's News Station:  Oct 27 2008 8:17PM
Matching: proteus
Find similar documents
HTML
100%
New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria
WASHINGTON, Oct.

27 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

(J&JPRD), today announced new study results that demonstrate doripenem (DORIBAX(TM), doripenem for injection), a...

KSLA:  Oct 27 2008 6:36PM
Matching: proteus
Find similar documents
HTML
100%
Prevalence and Mechanisms of Broad-Spectrum -Lactam Resistance in Enterobacteriaceae: a Children's Hospital E
The objective of this study was to investigate the trends and patterns of resistance in -lactamase-producing members of the family Enterobacteriaceae in a children's hospital over a 9-year period (1999 to 2007).

Clinically significant...

AAC:  Oct 24 2008 9:28AM
Matching: proteus
Find similar documents
HTML
100%
Proteus Biomedical raises $32 million in equity financing
New corporate investors Medtronic and Itochu join existing investors St Jude Medical, Adams Street Partners, The Carlyle Group, Essex Woodlands, Kaiser Permanente Ventures, Spring Ridge Ventures and others.

The company's current round of...

Pharmaceutical Business Review:  Oct 17 2008 3:13AM
Matching: proteus
Find similar documents
HTML
100%
Proteus Biomedical raises $32M new funding
Redwood City-based Proteus said investors included The Carlyle Group and Adams Street Partners, which have offices in Menlo Park; and Essex Woodlands, which has an office in Palo Alto.

The company said its current round of financing...

Biz Journals:  Oct 15 2008 8:22PM
Matching: proteus
Find similar documents
HTML
100%
Proteus Biomedical raises $32M new funding
Redwood City-based Proteus said investors included The Carlyle Group and Adams Street Partners, which have offices in Menlo Park; and Essex Woodlands, which has an office in Palo Alto.

The company said its current round of financing...

East Bay Business Journal:  Oct 15 2008 1:37PM
Matching: proteus
Find similar documents
HTML
100%
Proteus Biomedical Raises $32 Million in Series D Funding
- Proteus Biomedical Inc., a pioneer in intelligent medicine, announced today that the company has raised $32 million in a series D equity financing.

New corporate investors Medtronic and Itochu join existing investors St.

Jude...

DiGiTAL50:  Oct 15 2008 6:49PM
Matching: proteus
Find similar documents
HTML
100%
Proteoglycan degrading mutants for the treatment of CNS
Title: United States Patent: 7,429,375 Inventors: Gruskin; Elliott A.

(Killingworth, CT), D'Souza; Rohini (Croton on Hudson, NY), Roy; Gargi (Danbury, CT), Caggiano; Anthony O.

(Larchmont, NY) Assignee: Acorda Therapeutics, Inc.

...

PharmCast:  Oct 15 2008 8:21PM
Matching: proteus
Find similar documents
HTML
100%
Antibodies to a polypeptide encoded by a nucleic acid overexpressed in melanoma
Title: United States Patent: 7,423,127 Inventors: Goddard; Audrey (San Francisco, CA), Godowski; Paul J.

(Hillsborough, CA), Grimaldi; J.

Christopher (San Francisco, CA), Gurney; Austin L.

(Belmont, CA), Wood; William I.

...

PharmCast:  Sep 27 2008 2:11AM
Matching: proteus
Find similar documents

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997- - BioPortfolio Limited.